Research [ASAP] Chk1-Targeted Hesperidin Liposomes for Breast Cancer Therapy: An Integrated In Silico, In Vitro, and In Vivo Evaluation LikeLiked Date: May 21, 2026 Less than 1 MinRead Views: 5 ACS Applied Bio Materials DOI: 10.1021/acsabm.6c00143 Source: http://dx.doi.org/10.1021/acsabm.6c00143 FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Enhanced biomethane production associated with olivine-stimulated CO2 reduction in petroleum reservoir production water Research July 1, 2026 Ontario potato growers urged to scout early for late blight Food & Agriculture June 30, 2026 NASA’s Chandra Reveals ‘Red, White, Blue’ Universe for US 250th Research June 30, 2026 Closed-loop recycling of End-of-Life tires via devulcanized rubber: Life Cycle Assessment and circularity evaluation with durability trade-offs Research June 30, 2026 Groundwork BioAg Issues First Verra Verified Soil Carbon Credits in U.S. Milestone Carbon Markets June 30, 2026 Amazon Backs Brazil-based GranBio to Turn Wood Waste into Sustainable Aviation Fuel Carbon Markets June 30, 2026 Lifestyle June 30, 2026 Ranked: Where It Costs the Most to Stay Cool in America Energy June 30, 2026 Ranked: Countries Building the Most Small Modular Nuclear Reactors Energy June 30, 2026 EU Adopts New Circularity Requirements for Vehicles Environmental News June 30, 2026 Load more
